SuperworthArtivion profit margin AORT
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −0.7%
- Operating margin, 12 months
- 4.4%
- Net margin on a year earlier
- +3.8 pts
- Peer median
- 7.7%
Over the twelve months to Jun 30, 2026, Artivion kept −0.7% of its revenue as net profit, with an operating margin of 4.4% and a gross margin of 64.4%.
Five years earlier its net margin was −4.2%.
The median for 10 medical instruments and supplies stocks of a similar size is 7.7%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 2.2% | 7.6% | 64.4% |
| FY2024 | −3.4% | 10.0% | 64.0% |
| FY2023 | −8.7% | 1.6% | 64.7% |
| FY2022 | −6.1% | 2.0% | 64.5% |
| FY2021 | −5.0% | 2.7% | 66.1% |
| FY2020 | −6.6% | 1.0% | 66.3% |
| FY2019 | 0.6% | 6.2% | 66.3% |
| FY2018 | −1.1% | 3.5% | 65.8% |
| FY2017 | 2.0% | 4.2% | 67.8% |
| FY2016 | 6.0% | 12.1% | 65.9% |
| FY2015 | 2.7% | 3.7% | 62.2% |
| FY2014 | 5.1% | 6.1% | 63.1% |
| FY2013 | 11.5% | 9.8% | 64.2% |
| FY2012 | 6.0% | 9.6% | 64.5% |
| FY2011 | 6.2% | 9.7% | 63.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −0.7% | +3.8 pts | 4.4% | |
| Q1 FY26 | 2.5% | +8.0 pts | 8.2% | |
| Q4 FY25 | 2.2% | +5.7 pts | 7.6% | |
| Q3 FY25 | −2.2% | −1.9 pts | 6.1% | |
| Q2 FY25 | −4.4% | −2.2 pts | 4.3% | |
| Q1 FY25 | −5.5% | −2.9 pts | 4.0% | |
| Q4 FY24 | −3.4% | +5.2 pts | 10.0% | |
| Q3 FY24 | −0.2% | +7.0 pts | 10.2% | |
| Q2 FY24 | −2.2% | +6.4 pts | 9.0% | |
| Q1 FY24 | −2.6% | +6.6 pts | 9.5% | |
| Q4 FY23 | −8.7% | −2.6 pts | 1.6% | |
| Q3 FY23 | −7.2% | +6.0 pts | 2.0% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Artivion's size, closest first, today.
| Company | Profit margin |
|---|---|
| AORTArtivion | −0.7% |
| STAAStaar Surgical | 1.1% |
| IRMDIradimed | 26.7% |
| BVSBioventus | 9.4% |
| CDRECadre | 5.3% |
| EYENational Vision | 2.5% |
| MOVMovado | 6.0% |
| LMATLemaitre Vascular | 25.0% |
| INSPInspire Medical Systems | 15.0% |
| MDXGMimedx | 1.8% |
| UFPTUFP Technologies | 11.4% |
| Peer median | 7.7% |
Where Artivion ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Artivion
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.